miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 507-512

  Sun, Chaoyang ^a   Li, Na ^a   Zhou, Bo ^a   Yang, Zongyuan ^a   Ding, Dong ^a   Weng, Danhui ^a   Meng, Li ^a   Wang, Shixuan ^a   Zhou, Jianfeng ^a   Ma, Ding ^a   Chen, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Carcinogenesis; Epithelial ovarian cancer; miR 222; P27Kip1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; LUCIFERASE; MICRORNA 222; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

3' UNTRANSLATED REGION; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 84879467383     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1393     Document Type: Article

References (19)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. No authors listed: Ovarian cancer, five-year stage-specific relative survival rates (2004-2008). J Natl Cancer Inst103: 1287, 2011.
3. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
4. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
5. Galardi S, Mercatelli N, Giorda E, etal: miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem282: 23716-23724, 2007.
6. Miller TE, Ghoshal K, Ramaswamy B, etal: MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem283: 29897-29903, 2008.
7. Zhang CZ, Zhang JX, Zhang AL, etal: MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer9: 229, 2010.
8. Lu Y, Roy S, Nuovo G, etal: Anti-microRNA-222 (anti-miR-222) and-181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal. J Biol Chem286: 42292-42302, 2011.
9. Stinson S, Lackner MR, Adai AT, etal: miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal4: pt5, 2011.
10. Stinson S, Lackner MR, Adai AT, etal: TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal4: ra41, 2011.
11. Yang CJ, Shen WG, Liu CJ, etal: miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. J Oral Pathol Med40: 560-566, 2011.
12. Wurz K, Garcia RL, Goff BA, etal: MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer49: 577-584, 2010.
13. Koff A: How to decrease p27Kip1 levels during tumor development. Cancer Cell 9: 75-76, 2006.
14. Duncan TJ, Al-Attar A, Rolland P, Harper S, Spendlove I and Durrant LG: Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer. Int J Gynecol Pathol29: 8-18, 2010.
15. Xing H, Wang S, Hu K, etal: Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy. J Cancer Res Clin Oncol131: 511-519, 2005.
16. Masciullo V, Sgambato A, Pacilio C, etal: Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res59: 3790-3794, 1999.
17. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Würl P and Taubert H: Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126: 73-80, 2010.
18. Visone R, Russo L, Pallante P, et al: MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14: 791-798, 2007.
19. Quintavalle C, Garofalo M, Zanca C, et al: miR-221/222 overexpression in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. Oncogene 31: 858-868, 2012.